Development of small-diameter vascular prostheses which release bioactive agents

Clin Mater. 1991;8(1-2):81-8. doi: 10.1016/0267-6605(91)90013-6.

Abstract

A porous, distensible, tubular membrane which incorporates albumin and basic Fibroblast Growth Factor (bFGF), and is potentially utilizable as a bioactive small-diameter vascular prosthesis, was fabricated by a combined spraying, phase-inversion technique using a suspension of albumin and bFGF into a polyetherurethane-urea (Biomer) solution in dimethylacetamide (DMA). Scanning electron microscopy showed a material with an open-cell trabecular structure and small particles of albumin and/or bFGF entrapped in the bulk of the polyurethane trabeculae. The material released albumin and bFGF at an approximately constant rate for at least 2 weeks. The bFGF initially incorporated in the polymer remained biologically active as shown by in-vitro proliferation of human endothelial cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Albumins / chemistry
  • Biological Assay / methods
  • Blood Vessel Prosthesis / instrumentation*
  • Cell Division
  • Endothelium, Vascular / cytology
  • Fibroblast Growth Factors / chemistry
  • Humans
  • Materials Testing
  • Polyurethanes / chemistry
  • Prosthesis Design

Substances

  • Albumins
  • Polyurethanes
  • Fibroblast Growth Factors